focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRuffer Regulatory News (RICA)

Share Price Information for Ruffer (RICA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 274.00
Bid: 273.00
Ask: 273.50
Change: 0.50 (0.18%)
Spread: 0.50 (0.183%)
Open: 273.50
High: 274.50
Low: 272.50
Prev. Close: 273.50
RICA Live PriceLast checked at -
Ruffer Investment Company is an Investment Trust

To achieve capital and income return of twice the Bank of England base rate by investing through internationally listed securities and bonds.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monthly Investment Report February 2021

8 Mar 2021 16:45

RNS Number : 5388R
Ruffer Investment Company Limited
08 March 2021
 

RUFFER INVESTMENT COMPANY LIMITED

(a closed-ended investment company incorporated in Guernsey with registration number 41996)

LEI 21380068AHZKY7MKNO47

 

 

Attached is a link to the Monthly Investment Report for February 2021.

 

http://www.rns-pdf.londonstockexchange.com/rns/5388R_1-2021-3-8.pdf

 

During February, the share price rose by 3.0% and the NAV rose by 4.3%. This compared with a rise of 2.0% in the FTSE All-Share index.

 

We always expected the journey to a post-covid world would be a bumpy ride, especially after the fireworks in stock markets last year, so we positioned the portfolio accordingly. With bond yields ending 2020 at extraordinarily low levels, it was only a matter of time before investors started to fret about a stronger than anticipated economic recovery in the coming months. February duly delivered the first of what may be several jolts to asset prices as bond yields rose sharply, gold sold off and equities fell back from all-time highs touched in mid-February.

 

We have long been aware of the risk to portfolio performance from a rise in bond yields. Accordingly, we accumulated small, but powerful, holdings in interest rate options at bargain prices last year to protect against the damage exactly such a move could do to our long-dated inflation-linked bonds. These interest rate options rose sharply in February, ensuring we made a good return despite falls in gold and inflation-linked bonds. In technical terms, the interest rate options reduced the overall duration of the portfolio to close to zero, eliminating the downside risk from rising bond yields, despite the fact we continue to hold about 15% of the fund in the longest duration inflation-linked bonds available in both the UK and US. At the same time, we continue to avoid other hidden 'long duration' assets such as the US mega-cap growth stocks.

 

Freed from the drag of falling bond prices, the fund made a healthy gain in February thanks to strong rises in the recovery-biased equities in the portfolio. Previously 'out of favour' holdings such as UK banks (Lloyds, Natwest and Barclays) rose by around 20%, the oil majors gained approximately 10% and Japanese banks had a moment in the sun with rises of up to 15%. The small amount of exposure to cryptocurrency held via the Ruffer Illiquid Multi Strategies Fund also contributed positively.

 

 

 

 

 

Viewed from 10,000 feet, however, the big picture remains the same. Our conviction of an inflationary end to these events is unshaken, but at some point markets were going to test central bankers' resolve to keep interest rates nailed to the floor once economies showed signs of recovery. There may well be more such tests to come, hence the fund consists of essentially three 'legs'. First, inflation-linked bonds, gold and cryptocurrency protect against higher inflation and financial repression. In fact, we have used the recent sell-off to add to inflation-linked bonds. Secondly, unconventional protections such as interest rate options and credit protections enable us to keep to our course through the likely squalls. Finally, recovery-oriented equities profit from the reopening of economies around the world.

 

Over the last 12 months, this all-weather approach delivered a return NAV return of 24.2% and a share price return of 31.7% with a low level of volatility while stock and bond markets fluctuated wildly, and we believe it remains well positioned for an uncertain future.

 

 

 

 

 

Enquiries:

 

Praxis Fund Services Limited

Gail Adams

DDI: +44(0)1481 755584

Email: ric@praxisifm.com 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEASDPELEFEFA
Date   Source Headline
28th Sep 20222:22 pmRNSNet Asset Value(s)
22nd Sep 20224:59 pmRNSIssue of Equity and Total Voting Rights
21st Sep 20224:58 pmRNSIssue of Equity and Total Voting Rights
21st Sep 20221:43 pmRNSNet Asset Value(s)
16th Sep 20227:00 amRNSKepler Trust Intelligence: New Research
15th Sep 20224:51 pmRNSIssue of Equity and Total Voting Rights
14th Sep 20225:09 pmRNSIssue of Equity and Total Voting Rights
14th Sep 20223:24 pmRNSNet Asset Value(s)
12th Sep 20227:00 amRNSBlock listing Interim Review
9th Sep 20227:00 amRNSMonthly Investment Report August 2022
8th Sep 20224:36 pmRNSIssue of Equity and Total Voting Rights
7th Sep 20224:52 pmRNSIssue of Equity and Total Voting Rights
7th Sep 20223:26 pmRNSNet Asset Value(s)
1st Sep 20225:09 pmRNSIssue of Equity & Total Voting Rights
1st Sep 20223:35 pmRNSNet Asset Value(s)
31st Aug 20224:35 pmRNSIssue of Equity & Total Voting Rights
31st Aug 20223:56 pmRNSNet Asset Value(s)
25th Aug 20225:08 pmRNSIssue of Equity & Total Voting Rights
24th Aug 20224:28 pmRNSIssue of Equity & Total Voting Rights
24th Aug 20223:18 pmRNSNet Asset Value(s)
17th Aug 20224:51 pmRNSIssue of Equity and Total Voting Rights
17th Aug 20223:44 pmRNSNet Asset Value(s)
11th Aug 20224:05 pmRNSIssue of Equity & Total Voting Rights
10th Aug 20224:59 pmRNSIssue of Equity and Total Voting Rights
10th Aug 20222:55 pmRNSNet Asset Value(s)
8th Aug 20227:00 amRNSMonthly Investment Report July 2022
4th Aug 20225:00 pmRNSIssue of Equity and Total Voting Rights
3rd Aug 20224:58 pmRNSIssue of Equity and Total Voting Rights
3rd Aug 20223:20 pmRNSNet Asset Value(s)
1st Aug 20223:34 pmRNSNet Asset Value(s)
29th Jul 20224:30 pmRNSTotal Voting Rights
28th Jul 20224:09 pmRNSIssue of Equity and Total Voting Rights
27th Jul 20224:27 pmRNSIssue of Equity and Total Voting Rights
27th Jul 202212:59 pmRNSNet Asset Value(s)
21st Jul 20225:02 pmRNSIssue of Equity and Total Voting Rights
20th Jul 20224:08 pmRNSIssue of Equity and Total Voting Rights
20th Jul 20222:26 pmRNSNet Asset Value(s)
18th Jul 20227:00 amRNSInvestment Manager’s Year End Review
14th Jul 20224:46 pmRNSIssue of Equity and Total Voting Rights
14th Jul 202212:00 pmRNSMonthly Investment Report June 2022
13th Jul 20225:35 pmRNSIssue of Equity and Total Voting Rights
13th Jul 20224:26 pmRNSNet Asset Value(s)
12th Jul 20228:30 amRNSPortfolio Management Team Update
7th Jul 20224:59 pmRNSIssue of Equity and Total Voting Rights
6th Jul 20224:58 pmRNSIssue of Equity and Total Voting Rights
6th Jul 20224:00 pmRNSNet Asset Value(s)
1st Jul 20223:52 pmRNSNet Asset Value(s)
30th Jun 20224:45 pmRNSTotal Voting Rights
29th Jun 20223:20 pmRNSNet Asset Value(s)
23rd Jun 20222:51 pmRNSIssue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.